Skip to main content

Table 2 Comparison between males and females

From: Health-related quality of Life in patients with chronic hepatitis C receiving Sofosbuvir-based treatment, with and without Interferon: a prospective observational study in Egypt

 

Mean ± Std. Deviation

t

Age

 • Male

49.48 ± 12.19

-3.68**

 • Female

58.34 ± 5.92

 

PCR-T0

 • Male = 28

890248.43 ± 1049454.60

2.22*

 • Female = 28

411320.44 ± 451668.92

 

BMI-T0

 • Male

29.10 ± 3.86

-2.83**

 • Female

31.99 ± 4.15

 

MBI-T1

 • Male

28.88 ± 3.83

-2.74**

 • Female

31.88 ± 4.71

 

HRQoL-T0

 • Male

23.73 ± 15.89

-3.43**

 • Female

39.06 ± 19.66

Symptom Severity-T0

 • Male

18.53 ± 10.30

-3.12**

 • Female

27.43 ± 12.28

Symptom Hindrance-T0

 • Male

5.20 ± 6.66

-3.27**

 • Female

11.62 ± 8.57

Depression-T0

 • Male

5.56 ± 5.88

-3.52**

 • Female

11.47 ± 7.19

Depression-T1

 • Male

7.20 ± 6.46

-2.32*

 • Female

11.28 ± 7.69

  1. Note: only significant results are presented, sample of male = 30 & female = 32
  2. PCR-T0 Polymerase Chain Reaction time0, BMI-T0 body mass index time 0, BMI-T1 body mass index time 1, HRQoL-T0 health-related quality of life time 0
  3. *P value: * ≤ .05, ** ≤ .001, *** ≤ .0001 at two tailed
Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us